TONIX PHARMACEUTICALS HOLDING CORP. Stock Issued During Period, Shares, Reverse Stock Splits
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Stock Issued During Period, Shares, Reverse Stock Splits of 245.21 thousand shares for the 0-month period ending 2024-06-10, per its 10-K filed 2025-03-18.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2025-03-18
- 2024-06-10: Stock Issued During Period, Shares, Reverse Stock Splits 0 month 245.21K shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits 0 month |
|---|---|
| 2024-06-10 | 245.21K shares 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |